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Abstract
Background: Diagnosis of African animal trypanosomosis is vital to controlling this severe disease which hampers
development across 10 million km2 of Africa endemic to tsetse flies. Diagnosis at the point of treatment is currently
dependent on parasite detection which is unreliable, and on clinical signs, which are common to several other
prevalent bovine diseases.
Methodology/Principle Findings: the repeat sequence of the GM6 antigen of Trypanosoma vivax (TvGM6), a
flagellar-associated protein, was analysed from several isolates of T. vivax and found to be almost identical despite
the fact that T. vivax is known to have high genetic variation. The TvGM6 repeat was recombinantly expressed in E.
coli and purified. An indirect ELISA for bovine sera based on this antigen was developed. The TvGM6 indirect ELISA
had a sensitivity of 91.4% (95% CI: 91.3 to 91.6) in the period following 10 days post experimental infection with T.
vivax, which decreased ten-fold to 9.1% (95% CI: 7.3 to 10.9) one month post treatment. With field sera from cattle
infected with T. vivax from two locations in East and West Africa, 91.5% (95% CI: 83.2 to 99.5) sensitivity and 91.3%
(95% CI: 78.9 to 93.1) specificity was obtained for the TvGM6 ELISA using the whole trypanosome lysate ELISA as a
reference. For heterologous T. congolense field infections, the TvGM6 ELISA had a sensitivity of 85.1% (95% CI:
76.8 to 94.4).
Conclusion/Significance: this study is the first to analyse the GM6 antigen of T. vivax and the first to test the GM6
antigen on a large collection of sera from experimentally and naturally infected cattle. This study demonstrates that
the TvGM6 is an excellent candidate antigen for the development of a point-of-treatment test for diagnosis of T.
vivax, and to a lesser extent T. congolense, African animal trypanosomosis in cattle.
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Introduction
African animal trypanosomosis (AAT) is a devastating
livestock disease costing approximately $1 -2 billion per annum
in Africa [1]. AAT is caused by the tsetse-fly-transmitted
(Glossina sp.) protozoan parasites Trypanosoma congolense,
T. vivax and to a lesser extent, T. brucei brucei and by the non-
tsetse transmitted trypanosomes such as T. evansi, the most
widely distributed animal pathogenic trypanosome, which is the
causative agent of surra [2]. Furthermore, T. vivax, in addition
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to being transmitted by tsetse flies, can also be transmitted by
biting flies in South America and regions of Africa non-endemic
to tsetse [3,4].
Disease progression is dependent on host factors as well as
on parasite species and strain. The most prevalent clinical
signs include anaemia, weight loss, reduced productivity,
infertility and abortion [5]. However, symptoms are too varied
and non-specific to be a reliable basis for diagnosis of AAT.
Unlike human African trypanosomosis, where a lateral flow
device prototype has recently been developed, no point-of-
treatment test exists for AAT [6,7]. The current gold standard
for diagnosis of AAT is examination of blood by light
microscopy for the presence of parasites. The blood can be
concentrated (usually by centrifugation) to improve sensitivity
[8]. However, the usefulness of parasitological diagnosis is
limited in chronic infections where the parasitaemia is low and
intermittent. Even during acute infection, antigenic variation
results in waves of parasitaemia which could easily be missed
if sampling is only performed a single time [9].
In terms of serological diagnosis, the indirect fluorescent
antibody test (IFAT) was one of the first antibody detections
tests to be used for diagnosis of AAT. The IFAT is both
sensitive and specific, but not species-specific [10].
Furthermore, the IFAT is not quantitative, requires fluorescent-
enabled microscopes, and antigen preparation is not
standardised. Antibody ELISA using whole trypanosomal lysate
(WTL) was subsequently developed as a serological test for
AAT [11]. Although it shows high sensitivity and specificity, the
WTL ELISA is not species-specific and, again, standardisation
of antigen production proves difficult. For these reasons, the
WTL ELISA is not readily adaptable to an immune-
chromatographic test format required for point of treatment
diagnosis in field situations. However, partial purification of the
crude lysate allows higher specificity [12]. Still, the general
problem with antibody detection tests is that they do not only
detect active infections, since antibodies against trypanosomes
persist after treatment or self-cure.
On the other hand, antigen detection ELISAs developed for
AAT suffer from low sensitivity and low species-specificity as
confirmed with experimental infections [13,14].
The GM6 antigen was originally identified in African
trypanosomes by screening a T. b. gambiense cDNA library
with infected bovine sera [15]. It has been shown that the GM6
antigen is an invariant antigen, associated with the flagellum
and expressed in both procyclic and bloodstream forms (BSF)
of the parasite [15]. The GM6 antigen contains a 68 amino acid
repeat motif which is partially conserved in T. brucei, T.
congolense and T. vivax. It has been noted that the GM6
antigens are part of the calpain superfamily, albeit with unusual
repeat sequences and are unlikely to be active enzymes [16].
To date, the T. vivax GM6 and T. congolense GM6 antigens
have not been tested in an ELISA to diagnose bovine
trypanosomosis. Furthermore, previous studies of the GM6
antigen ELISA have been limited to small sets of infected sera,
and almost exclusively from experimental infections.
Currently, the treatments available for AAT are not species-
specific. However, since no field diagnostic test is currently
available for any animal trypanosome infections, diagnosis of
T. vivax infection would be a good beginning. Primarily, the
goal would be to incorporate antigens from both T. congolense
and T. vivax into a pan-trypanosome field diagnostic test.
Secondly, specific detection of T. vivax would be useful since
this parasite is prevalent in both East and West Africa, in both
tsetse endemic and non-endemic regions, as well as in South
America. T. vivax is also responsible for haemorrhagic
outbreaks of AAT, which would benefit from quick diagnosis
[17]. Also, the natural habitat of tsetse is being reduced by
climate change, encroaching human settlements and tsetse
eradication programs [18]. For this reason, it is foreseeable that
T. vivax could become more prevalent than T. congolense
given that it does not require tsetse for transmission. Indeed,
this has already been observed in the northern arid Djibo
region of Burkina Faso [19].
For these reasons, in the current study, the repeat
sequences of the GM6 proteins of T. vivax (TvGM6:
TvY486_1101010) and T. congolense (TcoGM6:
TcIL3000.11.1030) were recombinantly expressed, and
purified. Sequencing of the TvGM6 genes from isolates from
both East and West Africa showed high conservation despite
the fact that T. vivax is known to be highly genetically diverse
[20,21,22,23,24,25]. The purified GM6 antigens were
subsequently used in an indirect ELISA that was optimised for
detection of trypanosome infection in bovine sera. Sera from
experimental infections using strains of T. vivax and T.
congolense from both East and West Africa were tested in an
indirect ELISA with the two GM6 antigens to determine the
kinetics of infection. In addition, large collections of field sera
were tested in order to determine the specificity and sensitivity
of the TvGM6 indirect ELISA for both homologous and
heterologous infections.
Materials and Methods
Ethics statement
All mice procedures were carried out in strict accordance
with the French legislation (Rural Code articles L 214-1 to L
214-122 and associated penal consequences) and European
Union (Directive 2010/63/EU Protection of Animals Used for
Scientific Purposes) guidelines for the care of laboratory
animals and were approved by the Ethical Committee of Centre
National de la Recherche Scientifique, Région Aquitaine and
by the University of Bordeaux 2 animal care and use
committee. All efforts were made to minimize animal suffering.
For the cattle infections at ClinVet in South Africa, the study
plan was submitted to the ClinVet Animal Ethics Committee
(CAEC) and an approval certificate was issued authorizing the
research facility to conduct the study. The study plan was
designed to allow the use of the study animals in compliance
with the ClinVet Policy on the ethical use of animals (CVI
08/03) using the South African National Standard “SANS
10386:2008 “The care and use of animals for scientific
purposes” as a reference.
The protocol for cattle studies conducted by CIRDES (Centre
International de Recherche-Développement sur l'Elevage en
Zone subhumide, Bobo-Dioulasso, Burkina Faso) were
reviewed and approved by the Scientific Committee of
Diagnosis of T.vivax Infections in Cattle
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CIRDES, and complied with the requirements of ‘European
Union Directive 2010/63/EU Protection of animals for scientific
purposes; Requirements for establishments and for the care
and accommodation of animals.
The research protocol for cattle infections at CB-UEM
(Biotechnology Centre at the University Eduardo Mondlane,
Maputo, Mozambique) was approved by the Scientific Board of
the Veterinary Faculty of the Eduardo Mondlane University.
The study was reviewed by The Mozambican Livestock
National Directorate and handling of the animals and blood
sampling were performed by approved staff, namely animal
technicians and veterinary surgeons, according to the World
Organization for Animal Health (OIE) guidelines for use of
animals in research and education.
Additionally, the cattle studies conducted at CIRDES, ClinVet
and CB-UEM were approved by the Scientific Committee of
GALVmed (Global Alliance for Livestock Veterinary Medicine)
in the frame of the Animal African Trypanosomosis Programme
(Aries code 202040-101).
GM6 cloning, expression and purification
The T. vivax Y486 strain was initially isolated from a Zebu in
West Africa (Nigeria) [26] and was kindly provided by the
International Livestock Research Institute, Nairobi, Kenya. A
fragment containing four copies of the repeat (270 bp) was
amplified from the T. vivax GM6 gene (TvGM6:
TvY486_1101010) using specific primers: Fwd: 5' GAA ATA
CAG CAG CAA CAC GAT 3'; Rv: 5' GAA CTG CTC GTC CGC
GTC AAG 3'. The amplicon was cloned into pGEX-4T-1 (GE
Healthcare) in frame with the 5' GST-tag. A similar fragment
(220 bp) of the T. congolense GM6 (TcoGM6:
TcIL3000.11.1030) was synthesised commercially, due to
cloning difficulties, (ProteoGenix, Oberhausbergen, France)
and cloned into pGEX-4T-1. Recombinant vectors were used to
transform Escherichia coli BL21 Star ™ (DE3) (Invitrogen,
Saint-Aubin, France) for expression. Cultures in mid-
exponential growth phase were induced with 0.4 mM IPTG for
3-4 hrs. Recombinant fusion protein was present in the
supernatant of cell lysate. Cells were lysed with an extraction
buffer (50 mM Tris-Cl, pH 8.5, 100 mM NaCl, 1 mM EDTA)
supernatants bound to Glutathione Sepharose 4B (GE
Healthcare) for 1 hr at room temperature (RT) with gentle
agitation. The resin was washed five times in extraction buffer
(10 column volumes) and resuspended in 1 ml thrombin
cleavage buffer (50 mM Tris pH 8.0, 150 mM NaCl, 2.5 mM
CaCl2). Thrombin (10 units, Sigma) was added to the resin and
incubated overnight at RT with gentle agitation. Fractions
containing cleaved GM6 protein were collected, and
concentration estimated by Bradford protein assay [27].
Trypanosome strains and serum origins
Sera were obtained from several sources. Sera from T.
congolense experimental infections with the strain MozO2J
(isolated in Mozambique; L. Neves, 2012) and KONT2/133
(isolated in Cameroon; [28]) were obtained from novel
trypanocide efficacy studies conducted at ClinVet
(Bloemfontein, South Africa) by GALVmed (Global Alliance for
Livestock Veterinary Medicine). For these studies, animals
were treated with either 7 mg/kg diminazene diaceturate or 1
mg/kg isometamidium chloride and novel compounds under
evaluation for efficacy against T. congolense and T. vivax. T.
vivax infections were conducted at CIRDES (Centre
International de Recherche-Développement sur l'Elevage en
Zone subhumide, Bobo-Dioulasso, Burkina Faso) by
GALVmed, using strains isolated in West Africa
(Komborodougou and Napie, isolated in Ivory Coast by S. Yao
Loukou; Gando Bongaly, isolated in Togo by S. Boma)
provided by Z. Bengaly. Animals were treated with 3.5 mg/kg of
diminazene diaceturate. T. vivax experimental infection sera
were also obtained from infections conducted at ILRI (Nairobi,
Kenya) using the strains IL2172 and IL3769 (Ugandan origin
[26]) and were provided by a co-author and E. Authié.
Additional T. vivax experimental infections were conducted in
Mozambique at CB-UEM using a local isolate (175J) and the
Y486 reference strain [29]. Corresponding parasitaemia was
estimated by phase contrast buffy coat [30]. T. vivax-infected
field sera from Western Senegal, characterised by whole
trypanosome lysate ELISA were provided by co-authors [31]. T.
vivax-infected field sera from Ethiopia characterised by ITS-
PCR were provided by co-authors [3]. T. congolense-positive
field sera (buffy coat and 18s PCR) and negative sera from
animals in a tsetse-free region were collected in the South of
Mozambique (Biotechnology Centre, University Eduardo
Mondlane, Maputo, Mozambique).
ELISA
Indirect ELISA was optimised for type and concentration of
blocking agent, coating antigen concentration and secondary
antibody concentration. Recombinant GM6 antigen was
purified as described above. T. congolense (IL3000) and T.
brucei brucei (AnTat 1) BSF parasites were obtained from in
vitro culture [32,33]. T. vivax (Y486) BSF parasites were
propagated in mice and purified either by centrifugation [34] or
DE-52 ion-exchange chromatography [35], from which whole
parasite lysate was prepared by osmotic lysis. Briefly, antigen
(4 µg/ml for TvGM6, 10 µg/ml for TcoGM6 and whole
trypanosome lysate) was diluted in carbonate coating buffer
(50 mM carbonate buffer, pH 9.6) and plates coated with 100 µl
per well and incubated overnight at 4°C. Blocking buffer (1%
horse serum in PBS) was added to the wells (200 µl/well) and
the plate incubated at 37°C for 1 h. Primary sera diluted in
blocking buffer (1/100) were added to the wells in duplicate
(100 µl/well) and incubated at 37°C for 2 h. The plates were
washed with 0.05% PBS-Tween-20 using either a squeeze
bottle or an automated microplate washer (ThermoFisher
Scientific WellWash 4 Mk 2 MicroPlate Washer). Secondary
antibody, rabbit anti-bovine horse-radish peroxidase conjugate
(Sigma) diluted in blocking buffer (1/4000), was added to the
wells (100 µl/well). Plates were washed as before and
commercial ABTS substrate-chromogen solution (KPL) added
(100 µl/well). Optical density (OD 405 nm) was measured
approximately 10-15 min after addition of the substrate
(FLUOStar OPTIMA fluorescence plate reader). Readings were
considered acceptable when the OD values for the positive and
negative control samples fell within specific ranges, with a
coefficient of variance less than 10%.
Diagnosis of T.vivax Infections in Cattle
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Known strong positive and negative bovine serum samples
(based on previous ELISAs) were added to each plate allowing
calculation of the percent positivity (PP) for each sample [36].
For experimental infection sera, combined weighted estimates
of sensitivity from sequential sera of nine infected animals and
the weighted standard errors with 95% confidence limits were
calculated according to Eisler et al., [13]. The significance of
the differences observed between the TvGM6 and TvWTL
ELISA was compared using the McNemar test using GraphPad
Software (GraphPad Software Inc.). For field sera, cut-offs
were established using a minimum of 10 PCR negative bovine
sera from areas non-endemic to tsetse (peri-urban Maputo,
Mozambique). Cut-offs were calculated as the mean PP added
to two standard deviations. Sera were tested in duplicate, and
each experiment was performed at least twice, allowing
estimation of the standard error for positive and negative
samples from each region.
Immunofluorescence
Anti-TvGM6 and anti-TcoGM6 sera were obtained by
immunising mice at two week intervals with initially 50 µg of
purified recombinant protein (in Freund’s Complete adjuvant),
followed by two boosters of 25 µg (Freund’s Incomplete
adjuvant). Parasite pellets were washed in phosphate saline
with glucose (PSG), resuspended in 320 µl fixing solution (3%
formaldehyde in PBS, freshly prepared) and incubated at RT
for 10 min. Fixing was blocked using 1 M glycine-Cl (80 µl) and
incubation at RT for 10 min. Fixed parasite suspension (20 µl)
was added to slide wells. Dried slides were blocked using 0.5%
BSA-PBS (50 µl/well) at RT for 10 min, followed by
permeabilisation of the cells using 0.1% Triton X-100 in PBS
(20 µl) for the same time. Primary antibody diluted in blocking
buffer (20 µl) was added to each well and incubated in a
humidified atmosphere for 1 hr. Primary antibodies used were
either mouse anti-TvGM6 sera (1/2000) or mouse anti-TcoGM6
sera (1/2000), and rabbit anti-paraflagellar rod (1/50). Slide
wells were washed using blocking solution (3x50 µl).
Secondary antibody diluted 1/100 in blocking buffer (20 µl) was
added to slide wells and incubated for 60 min. Secondary
antibodies used were Alexa Fluo 488 conjugated goat anti-
mouse IgG and Texas Red® conjugated goat anti-mouse IgG
(Invitrogen, Carlsbad, CA, USA). DAPI (20 µl/ slide well) diluted
in PBS (final 0.5 µg/ml) was added to each slide well. Slides
were viewed using a Zeiss Axio Imager Z1 fluorescent
microscope and images captured using the MetaMorph®
software (Molecular Devices, CA, USA) at a total magnification
of 100x.
Results
TvGM6 is conserved within T. vivax isolates and is
possibly flagellar-associated
TvGM6 is a homolog of the genes found in T. brucei brucei
(Tb11.57.0008) and T. congolense (TcIL3000.11.1030).
However, the TvGM6 repeat sequence only shares 51 and
55% identity and 72 and 64% similarity with the homologs of
T. b. brucei and T. congolense, respectively (Figure 1A).
Furthermore, the number of repeats of the 68 amino acid motif
differs between the different species. The TvGM6 has 11
copies of the repeat compared to 60 in T. b. brucei and 9 in T.
congolense. In order to determine the level of variability in the
TvGM6 gene within the T. vivax species, the repeat was
sequenced from several T. vivax strains isolated in different
regions. As is evident from Figure 1B there were, at most, two
amino acid substitutions in a single copy of the TvGM6 repeat.
T. vivax strains from Burkina Faso had only one amino acid
substitutions in comparison to the T. vivax Y486 reference
strain.
Immuno-localisation studies (Figure 1C) showed that anti-
TvGM6 antibodies partially co-localised with anti-paraflagellar
rod antibodies. This indicated that the TvGM6, like the
homologs in other trypanosome species, is likely to be
associated with the flagellum. The co-localisation with the anti-
PFR antibodies was only partial, indicating that the localisation
of the TvGM6 is not entirely flagellar, and it is possible that the
TvGM6 may be present in the flagellar attachment zone.
TvGM6 was detected in both bloodstream form and procyclic
parasites (data not shown). An idential localisation pattern was
observed using anti-TcoGM6 antibodies (data not shown).
TvGM6 and TcoGM6: Detection of infection during T.
vivax and T. congolense experimental infections
In total, sera from nine T. vivax experimental infections were
tested with the TvGM6 ELISA: three with West African isolates,
two with East African isolates from Uganda, two with a
Mozambican isolate and two with the Y486 reference strain
(Nigerian origin [29]). A representative result (only one animal
per infection) of the TvGM6 indirect ELISA with a T. vivax
experimental infection compared to the ELISA using whole
trypanosome lysate of T. vivax (TvWTL) is shown in Figure 2A
and 2B.
The TvGM6 ELISA was positive 20 to 30 days post infection
(DPI), and reduced to baseline approximately 20 to 30 days
post-treatment when the animal was successfully treated
(Figure 2A). In Figure 2B, the TvGM6 ELISA was tested with
samples from an infection using a drug-resistant strain. In this
case, the parasitaemia decreased post-treatment and no
parasites were detected between 35 and 90 DPI. However, a
relapse was observed around 91 DPI, when parasites were
again detected in the blood. The antibody response against
TvGM6 decreased at 70 DPI (approximately one month after
treatment) and increased again 80 DPI, 15 days prior to the
detection of parasites by microscopy. These results suggest
that this antigen could be used to diagnose an active infection,
and, furthermore, would be a good indicator of the efficacy of
treatment. The TvWTL ELISA did not decrease as quickly (or at
all) as the TvGM6 ELISA after treatment.
Indirect ELISA using TcoGM6 during T. congolense
experimental infection is shown in Figures 2C (drug-sensitive
strain) and 2D (drug-resistant strain). A peak of antibody
response was observed at 25 DPI, and decreased dramatically
post-treatment (Figure 2C), however, this was only observed
for sera from five out of a total of eleven experimental
infections. In the other six experimental infections, no ELISA
response to TcoGM6 was observed (data not shown).
Therefore, detection of early infection using TcoGM6 ELISA,
Diagnosis of T.vivax Infections in Cattle
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during the first waves of parasitaemia, was inconsistent. As can
be seen in Figure 2D, the initial antibody response is barely
detectable 25 DPI, whereas the response continues to increase
after several waves of parasitaemia.
Comparative values for positivity of the TvGM6 ELISA, whole
trypanosome lysate (TvWTL) ELISA, and buffy coat during
experimental infection with T. vivax are shown in Table 1. The
TvWTL ELISA showed approximately double the sensitivity of
either the TvGM6 ELISA or the buffy coat method very early in
infection. However, the two-tailed P-value calculated using the
McNemar test was 0.2482 indicating that the difference
between the TvWTL and TvGM6 ELISAs was not significant.
Later than 10 DPI, the TvGM6 ELISA and the TvWTL ELISA
were comparable at approximately 90% of sensitivity (no
significant difference P-value = 0.6831) while the buffy coat
method was only 24% sensitive. Finally, the TvGM6 ELISA
results were 4.5 times less likely to be positive 30 days post-
treatment than the TvWTL ELISA results. The McNemar test P-
value was 0.0133 indicating that the TvGM6 ELISA was
significantly less likely to detect false positives post-treatment
than the TvWTL ELISA.
TvGM6: High specificity and sensitivity in field
infections
TvGM6 indirect ELISA was used to test sera from cattle
infected with T. vivax originating from Ethiopia, Senegal and
Mozambique (Table 2). TvGM6 ELISA showed a mean
(weighted) sensitivity of 91.5% (95% CI: 83.2 to 99.5) and a
mean (weighted) specificity of 91.3% (95% CI: 78.9 to 93.1) in
comparison to the TvWTL ELISA. In terms of a comparison to
PCR (not shown), for the Ethiopian field sera, the TvGM6
ELISA had a sensitivity of 79% compared to PCR positive
samples (268 tested), whereas the WTL ELISA had a lower
sensitivity of 68%. The lower specificity for the Senegalese and
Ethiopian sera (85.4 ± 6.9%) could be attributed to the fact that
the negative sera were obtained from an endemic region, i.e. it
cannot be excluded that animals were previously infected and
treated. Since the TvGM6 indirect ELISA requires a minimum
of 20-30 days post treatment to return to baseline values (as
seen from the experimental infections), it is possible that some
animals which test serologically positive had been infected and
treated within one month of serum collection.
In addition, the TvGM6 ELISA was negative (below the cut
off for positivity) when tested with bovine sera from animals
infected with Anaplasma marginale, Babesia bigemina and
Theileria buffeli (Marula) (results not shown).
Figure 1.  TvGM6 is a homolog of the protein found in other trypanosomes, is conserved within T, vivax isolates and is
flagellar associated.  (A) Alignment of the GM6 repeat motif from T. brucei brucei (427), T. congolense (IL3000) and T. vivax
(Y486). (B) Sequence alignment of a single repeat of the TvGM6 sequence from T. vivax isolates originating from Burkina Faso (BF)
and Ethiopia (ET). The T. vivax Y486 reference strain is shown. Background colour indicates conservation (black), similarity (grey)
and differences (white) in amino acid sequence. (C) Immunofluorescence microscopy of T. vivax Y486 bloodstream forms showing
partial co-localisation of anti-TvGM6 antibodies (green) with anti-paraflagellar rod (PFR) antibodies (red).
doi: 10.1371/journal.pone.0078565.g001
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TvGM6 : Cross-reactions with heterologous T.
congolense infection
The TvGM6 ELISA was also tested with sera from T.
congolense experimental infections, and produced a pattern
similar to the TcoGM6 indirect ELISA (data not shown), with a
peak of antibody response 25 DPI and a rapid decrease below
the threshold post-treatment. However, the TvGM6 ELISA was
consistently weaker than the TcoGM6 ELISA when detecting
heterologous infection. Due to this initial finding of a cross-
reaction, it was decided to test the TvGM6 indirect ELISA with
T. congolense-infected field sera to determine the sensitivity of
this test for the heterologous infection and the results are
shown in Table 3. The sensitivity of TvGM6 ELISA with T.
congolense field infections gave a mean sensitivity of 85%
(95% CI: 76.8 to 94.4) in comparison to the whole trypanosome
lysate ELISA.
Discussion
Diagnosis of AAT is currently made on the basis of clinical
signs, which are common to several other bovine pathogens,
resulting in frequent misdiagnosis. Currently, no point-of-
treatment diagnostic tool exists for diagnosis for either T.
congolense or T. vivax infections. Furthermore, detection of
either parasite would require the same intervention since there
is no difference in treatment. In the current study, the
immunodiagnostic potential of the T. vivax GM6 antigen for the
detection of T. vivax has been explored as the first step
towards a pan-trypanosome point-of –treatment diagnostic tool.
In the current study, the repeat motif of the GM6 antigens of
T. vivax (TvGM6) and T. congolense (TcoGM6) were
expressed and purified and their immunodiagnostic potential
tested in an indirect ELISA with sera from cattle infected with
either T. vivax or T. congolense. T. vivax is known to be quite
genetically diverse and several studies have shown that West
African and South American T. vivax strains are genetically
distinct from East African isolates [21,22,23,37]. For this
Figure 2.  Representative TvGM6 and TcoGM6 ELISA analysis of longitudinal experimental infection sera with (A, B) T.
vivax and (C,D) T. congolense in individual animals.  TvGM6 ELISA using sera from infections with (A) T. vivax IL2172 (drug-
sensitive) and (B) T. vivax Komborodougou (drug-resistant). TcoGM6 ELISA using sera from infections with (C) T. congolense O2J
(drug-sensitive) and (D) T. congolense KONT2/133 (drug-resistant). All animals were treated with 3.5mg/kg of diminazene
diaceturate at the dates indicated by the arrows, (D) was treated a second time with 1 mg/kg isometamidium chloride. For figures
(A), (C) and (D) parasitaemia score can be related to approximate amounts of parasites as follows: 2 (1-10/preparation), 3(1-2/field),
4 (1-10/field), 5 (10-50/>50 field), 6 (>100/field). TvGM6 or TcoGM6 ELISA OD (£), whole trypanosome lysate ELISA OD () and
parasitaemia () are indicated. Arrows indicate trypanocidal treatment, and the x-axis is the threshold for positivity.
doi: 10.1371/journal.pone.0078565.g002
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reason, sequencing of the TvGM6 gene from isolates
originating from both East and West Africa was deemed
necessary to confirm that the sequence was sufficiently
conserved to allow detection of infected animals in both
regions.
Table 1. Sensitivity of TvGM6 ELISA compared to TvWTL
ELISA and buffy coat in T. vivax experimental infections.
Point of
Infection Test
No. of
cattle
No. of
Samples Sensitivity a %95% CIb
< 10 DPI d TvGM6 ELISA 9 26 24.0 17.5 to 30.4
 TvWTL
c
ELISA 9 26 34.6 29.8 to 39.4
 Buffy Coat 9 32 15.6 14.7 to 16.6
> 10 DPI d TvGM6 ELISA 9 116 91.4 91.3 to 91.6
 TvWTL ELISA 9 116 90.5 90.4 to 90.7
 Buffy Coat 9 213 23.9 23.8 to 24.0
30 DPT e TvGM6 ELISA 4 21 9.1 7.3 to 10.9
 TvWTL ELISA 4 21 42.9 9.9 to 75.5
 Buffy Coat 2 15 0 0
aCombined sensitivity values were weighted for the number of samples per animal
b95% confidence interval
cT. vivax whole trypanosome lysate
ddays post infection
edays post treatment
doi: 10.1371/journal.pone.0078565.t001
Table 2. Sensitivity and specificity of TvGM6 ELISA
compared to the whole trypanosome lysate ELISA in T.
vivax field infections.
 Region Samples Sensitivity (%) ± SD a Mean (95% CI) b
Positives Ethiopia 179 94.4 ± 5.5 91.5 (83.2 to 99.5)
 Senegal 211 89.1 ± 7.4  
 Region Samples Specificity (%) ± SD a Mean (95% CI) b
Negatives Mozambique 84 96.4 ± 9.0 91.3 (78.9 to 93.1)
 Ethiopia 36 86.1 ± 2.0  
 Senegal 41 85.4 ± 6.9  
astandard deviation
b95% confidence interval
doi: 10.1371/journal.pone.0078565.t002
Table 3. Sensitivity of TvGM6 ELISA against T. congolense
field sera from two different regions.
Region Total Sensitivity (%) ± SD a Mean (95% CI) b
Ethiopia 28 89.6 ± 4.7 85.1 (76.8 to 94.4)
Mozambique 165 81.7 ± 2.7  
a. standard deviation
b. 95% confidence interval
doi: 10.1371/journal.pone.0078565.t003
As shown with the T. brucei GM6, this study confirmed that
the TvGM6 was present in both bloodstream form and procyclic
parasites. Immuno-localisation of the TvGM6 indicated that,
similar to the TbGM6, the T. vivax antigen was likely to be
located in the flagellar attachment zone.
Previous preliminary diagnostic studies had been done with
the GM6 antigen from different trypanosome species, including
a recombinant beta-galactosidase-T. b. gambiense GM6 fusion
protein which showed high immunodiagnostic sensitivity with
sera from T. brucei and T. congolense-infected cattle [15]. The
T. b. brucei GM6 (TbbGM6) antigen was tested in an antibody
ELISA for T. evansi infection, but was not sufficiently sensitive
[38]. However, it was useful in a competitive ELISA using T.
evansi infected bovine or buffalo sera, but not wallaby, pig, dog
or horse-infected sera [38]. Thuy et al., (2011) searched for
repeat antigens of T. congolense for use in a diagnostic test for
T. evansi. They identified TcoGM6 and TbbGM6 as potential
antigens since both showed higher reactivity to T. evansi –
infected water buffalo sera than other repeat antigens [39].
It is known that repeat antigens are good targets for B-cell
responses [40]. This may explain why the TvGM6, which is a
minor, insoluble antigen, has a high sensitivity in an indirect
ELISA. In fact, antibody responses against repeat proteins of
several protozoan parasites have been found, including for
malaria [41], Chagas disease [42] and leishmaniasis [43].
In the current study, sera from longitudinally-followed
experimental infections allowed definition of the kinetics of the
antibody response to these antigens, including the length of the
period post-infection before antibodies became detectable (pre-
patent period) and, most importantly, the time necessary for the
antibody response to decrease below the threshold post-
treatment. Sera obtained from naturally infected animals in the
field were tested in order to determine the level of sensitivity
and specificity of the GM6 antigen indirect ELISA. To ensure
that the GM6 ELISA was not strain or isolate specific, sera from
distinct geographic regions were tested. This is especially
significant in the case of T. vivax, since the TvGM6 ELISA gave
similar results for experimental infections conducted with
strains originating from Burkina Faso, Nigeria, Uganda and
Mozambique.
Based on the experimental infections, it is clear that the
antibody response against TvGM6 decreases to baseline
approximately one month after treatment. This could imply that
certain field sera which tested negative on PCR were positive
on the GM6 indirect ELISA due to persistence of antibodies
after treatment. Previous studies have shown that antibodies
against the WTL can persist for 10-13 months post treatment
[44,45]. However, Authié et al. (1993) indicated that although
animals treated 10 months previously tested positive in a WTL
ELISA, a western blot with the WTL indicated that only
antibodies recognising a few specific antigens were still
present. Given that the GM6 is a relatively minor, insoluble
antigen, it is probable that a certain level of parasitaemia is
necessary to stimulate a B-cell response. In the absence of this
stimulation, when the parasitaemia drops beneath the
necessary parasite load, the antibody response is short-lived.
Experimental infections showed that the antibody response
to the TvGM6 was detected at the earliest, 10 days post
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infection, during which period the PCR results were likely to be
positive. Therefore, the TvGM6 indirect ELISA may show false
negatives for animals which have been recently (less than 10
days) infected. The onset of anaemia, the most prevalent
clinical sign, occurs at approximately at the same time as the
emergence of detectable parasitaemia (1-3 weeks depending
on infecting strain, infective dose and host genetics) [5].
Therefore, the detection of infection using the TvGM6 ELISA
would be similar to the clinical pre-patent period. It was found
that the TvGM6 ELISA has a similar sensitivity to the WTL
ELISA later than 10 days post infection, but the antibody
response to TvGM6 decreased less than one month post
treatment, whereas the antibodies against the WTL tended to
persist for a longer period.
The case of the TvGM6 antigen cross-reacting with T.
congolense-infected sera is probably due to the few regions
which are sufficiently conserved to provide common epitopes
between the two species. However, the cross-reaction detected
is lower than with the homologous antigen. Furthermore, this
cross-reaction of the TvGM6 ELISA with T. congolense-
infected sera indicates that the TvGM6 ELISA alone cannot be
used for species-specific diagnosis. However, since the GM6
ELISA was consistently stronger when the homologous antigen
was used, testing sera with both the TcoGM6 ELISA and
TvGM6 ELISA would allow a relative response to be measured
and, therefore, tentative diagnosis of the trypanosome species.
TcoGM6 gave inconsistent results when tested with sera
from experimental T. congolense infections, and subsequently
did not always detect early infection. However, the antibody
response did increase following several waves of parasitaemia
which may imply that the TcoGM6 would only detect secondary
or re-current infections. Although the mechanism responsible is
unknown, this phenomenon has already been encountered with
the HSP70-based indirect ELISA and inhibition ELISA [46,47].
In summary, the TvGM6 ELISA allowed reliable detection of
antibody response around 10-20 DPI with T. vivax infections,
and decreased below the threshold less than one month
following treatment, to date, the best characteristic of a
trypanosome indirect ELISA. These results indicate the TvGM6
ELISA would essentially allow detection of active T. vivax
infection, making it ideal for a point-of-treatment diagnostic tool.
This would be of particular significance in South America,
where a high proportion of the cattle are infected but display no
symptoms [48]. Given that the TvGM6 ELISA does not detect
infections one month post failed treatment prior to relapse
(when the parasite is not detectable in the blood), it is likely that
the test would not be positive for the apparent silent infections
in South America and this would allow the discrimination of
only active infections requiring treatment. However, due to the
fairly rapid antibody decay post treatment, the TvGM6 ELISA
would not be suitable as a test for exposure to T. vivax.
Furthermore, the TvGM6 ELISA detected a failure of treatment
at least 15 days prior to the buffy coat method. Finally, the
TvGM6 indirect ELISA showed high sensitivity and specificity
values in field infections for T. vivax infections and slightly
lower values for T. congolense infection.
For T. congolense, it was noted that the TvGM6 ELISA
worked better in field conditions than experimental infections,
possibly due to the fact that only secondary or recurrent
infections are detected using this test. This hypothesis still
needs to be confirmed. As mentioned previously, the ultimate
goal would be to incorporate antigens from both T. congolense
and T. vivax into a pan-trypanosome point-of-treatment
diagnostic tool. To this end, the data presented in this study
motivate that the TvGM6 would be a good antigen for the
detection of T. vivax infections, but not necessarily for T.
congolense infections. For detection of T. evansi, it was shown
that the T. brucei GM6 did not give sufficiently high specificity
(approximately one-third) [38], therefore, it is unlikely that the T.
vivax or T. congolense GM6 antigens would perform better. A
difficulty with the field sera was first to determine which method
to use as a reference since the different sera collections had
been characterised using different techniques (either ITS-PCR,
18s PCR, whole trypanosome lysate ELISA, or buffy coat).
Given that these methods are not infallible, comparative
sensitivity and specificity values of the TvGm6 ELISA should
be interpreted carefully. It is possible that some field infections
detected as false negatives with the TvGM6 ELISA were at a
very early point in infection, since the experimental infections
indicated that TvGM6 ELISA showed a very low sensitivity less
than 10 days post infection. Conversely, a possible explanation
for some false positives with the field sera is that some animals
could have been treated less than one month prior to serum
collection. Based on the TvGM6 ELISA in experimental
infections, these animals would continue to test positive for one
month post treatment even if treatment was successful.
Although sera from T. vivax infections across East and West
Africa were analysed during the course of this study, no
analysis was done of South American T. vivax infections. This
analysis would be useful T. vivax infection is estimated to be
the third most economically important bovine parasitic infection
in South America [4].
This study represents the first analysis of the GM6 antigen of
T. vivax as a diagnostic candidate for AAT, and is the first to
test the GM6 antigen with a wide range of both experimental
and field T. vivax- infected sera from various locations. The
data reported here demonstrate the potential of the TvGM6
antigen for the development of a point-of-treatment test for
diagnosis of T. vivax in cattle. The TvGM6 ELISA could also be
used for detection of T. congolense, albeit with lower
sensitivity.
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